Logo image of ANGO

ANGIODYNAMICS INC (ANGO) Stock Fundamental Analysis

NASDAQ:ANGO - Nasdaq - US03475V1017 - Common Stock

11.94  -0.49 (-3.94%)

After market: 11.8 -0.14 (-1.17%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to ANGO. ANGO was compared to 191 industry peers in the Health Care Equipment & Supplies industry. ANGO scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. ANGO has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year ANGO has reported negative net income.
ANGO had a negative operating cash flow in the past year.
In the past 5 years ANGO always reported negative net income.
In multiple years ANGO reported negative operating cash flow during the last 5 years.
ANGO Yearly Net Income VS EBIT VS OCF VS FCFANGO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M -100M -150M

1.2 Ratios

With a Return On Assets value of -77.08%, ANGO is not doing good in the industry: 77.37% of the companies in the same industry are doing better.
With a Return On Equity value of -120.32%, ANGO is not doing good in the industry: 66.84% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -77.08%
ROE -120.32%
ROIC N/A
ROA(3y)-24.22%
ROA(5y)-21.27%
ROE(3y)-36.59%
ROE(5y)-30.72%
ROIC(3y)N/A
ROIC(5y)N/A
ANGO Yearly ROA, ROE, ROICANGO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60 -80

1.3 Margins

ANGO has a Gross Margin (52.71%) which is in line with its industry peers.
ANGO's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for ANGO so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 52.71%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.88%
GM growth 5Y-2.46%
ANGO Yearly Profit, Operating, Gross MarginsANGO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 -60

More info and screens

5

2. Health

2.1 Basic Checks

ANGO does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ANGO has been increased compared to 1 year ago.
ANGO has more shares outstanding than it did 5 years ago.
ANGO has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
ANGO Yearly Shares OutstandingANGO Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
ANGO Yearly Total Debt VS Total AssetsANGO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

Based on the Altman-Z score of 1.75, we must say that ANGO is in the distress zone and has some risk of bankruptcy.
ANGO's Altman-Z score of 1.75 is in line compared to the rest of the industry. ANGO outperforms 57.37% of its industry peers.
ANGO has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 1.75
ROIC/WACCN/A
WACC8.99%
ANGO Yearly LT Debt VS Equity VS FCFANGO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

A Current Ratio of 1.98 indicates that ANGO should not have too much problems paying its short term obligations.
The Current ratio of ANGO (1.98) is worse than 65.79% of its industry peers.
A Quick Ratio of 1.24 indicates that ANGO should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.24, ANGO is doing worse than 65.79% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.98
Quick Ratio 1.24
ANGO Yearly Current Assets VS Current LiabilitesANGO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

More info and screens

3

3. Growth

3.1 Past

The earnings per share for ANGO have decreased strongly by -105.56% in the last year.
Looking at the last year, ANGO shows a very negative growth in Revenue. The Revenue has decreased by -13.06% in the last year.
The Revenue has been growing slightly by 2.35% on average over the past years.
EPS 1Y (TTM)-105.56%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%20%
Revenue 1Y (TTM)-13.06%
Revenue growth 3Y1.46%
Revenue growth 5Y2.35%
Sales Q2Q%-7.87%

3.2 Future

The Earnings Per Share is expected to grow by 34.05% on average over the next years. This is a very strong growth
Based on estimates for the next years, ANGO will show a small growth in Revenue. The Revenue will grow by 7.03% on average per year.
EPS Next Y-4.62%
EPS Next 2Y17.15%
EPS Next 3Y33.25%
EPS Next 5Y34.05%
Revenue Next Year-3.03%
Revenue Next 2Y2.19%
Revenue Next 3Y5.45%
Revenue Next 5Y7.03%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ANGO Yearly Revenue VS EstimatesANGO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 100M 200M 300M
ANGO Yearly EPS VS EstimatesANGO Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 0.2 -0.2 0.4 -0.4 0.6 0.8

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

ANGO reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year ANGO is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ANGO Price Earnings VS Forward Price EarningsANGO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 -40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ANGO Per share dataANGO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

ANGO's earnings are expected to grow with 33.25% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y17.15%
EPS Next 3Y33.25%

More info and screens

0

5. Dividend

5.1 Amount

ANGO does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ANGIODYNAMICS INC

NASDAQ:ANGO (1/21/2025, 8:00:00 PM)

After market: 11.8 -0.14 (-1.17%)

11.94

-0.49 (-3.94%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)01-08 2025-01-08/bmo
Earnings (Next)N/A N/A
Inst Owners81.77%
Inst Owner Change-0.44%
Ins Owners5.2%
Ins Owner Change2.28%
Market Cap485.12M
Analysts84.44
Price Target13.26 (11.06%)
Short Float %2.3%
Short Ratio1.41
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)45.41%
Min EPS beat(2)26.47%
Max EPS beat(2)64.35%
EPS beat(4)3
Avg EPS beat(4)34.89%
Min EPS beat(4)-15.98%
Max EPS beat(4)64.71%
EPS beat(8)5
Avg EPS beat(8)-15.16%
EPS beat(12)8
Avg EPS beat(12)23.44%
EPS beat(16)11
Avg EPS beat(16)9.27%
Revenue beat(2)1
Avg Revenue beat(2)-0.96%
Min Revenue beat(2)-2.6%
Max Revenue beat(2)0.69%
Revenue beat(4)1
Avg Revenue beat(4)-1.59%
Min Revenue beat(4)-2.67%
Max Revenue beat(4)0.69%
Revenue beat(8)1
Avg Revenue beat(8)-2.38%
Revenue beat(12)2
Avg Revenue beat(12)-2.2%
Revenue beat(16)5
Avg Revenue beat(16)-1.08%
PT rev (1m)0%
PT rev (3m)-2.5%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-5.42%
EPS NY rev (1m)0%
EPS NY rev (3m)1.64%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-4.52%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.18%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.69
P/FCF N/A
P/OCF N/A
P/B 2.6
P/tB 4.27
EV/EBITDA N/A
EPS(TTM)-0.37
EYN/A
EPS(NY)-0.24
Fwd EYN/A
FCF(TTM)-0.73
FCFYN/A
OCF(TTM)-0.57
OCFYN/A
SpS7.05
BVpS4.6
TBVpS2.8
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -77.08%
ROE -120.32%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 52.71%
FCFM N/A
ROA(3y)-24.22%
ROA(5y)-21.27%
ROE(3y)-36.59%
ROE(5y)-30.72%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.88%
GM growth 5Y-2.46%
F-Score5
Asset Turnover0.98
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 22.55%
Cap/Sales 2.2%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.98
Quick Ratio 1.24
Altman-Z 1.75
F-Score5
WACC8.99%
ROIC/WACCN/A
Cap/Depr(3y)16.52%
Cap/Depr(5y)20.29%
Cap/Sales(3y)1.51%
Cap/Sales(5y)1.84%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-105.56%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%20%
EPS Next Y-4.62%
EPS Next 2Y17.15%
EPS Next 3Y33.25%
EPS Next 5Y34.05%
Revenue 1Y (TTM)-13.06%
Revenue growth 3Y1.46%
Revenue growth 5Y2.35%
Sales Q2Q%-7.87%
Revenue Next Year-3.03%
Revenue Next 2Y2.19%
Revenue Next 3Y5.45%
Revenue Next 5Y7.03%
EBIT growth 1Y-28.25%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year107.33%
EBIT Next 3Y46.49%
EBIT Next 5Y42.76%
FCF growth 1Y-33.05%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-33.32%
OCF growth 3YN/A
OCF growth 5YN/A